Graves Disease, hemolytic anemia, Myasthenia Gravis)
Katz, director of Yale University Prevention Research Center, Griffin Hospital, conducted a study on the efficacy of IV micronutrient therapy for fibromyalgia patients, with some promise
This review has deliberately distinguished failed biology from failed pharmacology, emphasizing that genuine on-target toxicity, repeated lack of efficacy in well-designed human studies, or insurmountable technical barriers justify abandonment
doi: 10.1053/j.semperi.2016.09.007, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 56.Takenouchi T, Sugiura Y, Morikawa T, Nakanishi T, Nagahata Y, Sugioka T, et al
Our team is here to help you
: : , , , ,